Illini O, Hund AC, Kopp HG, Moskovitz M, et al. Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort. J Thorac Oncol 2026 Feb 24:103651. doi: 10.1016/j.jtho.2026.103651.
PMID: 41747890